Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 15,330 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
INVARIANT LLC for FAMILY VOICES
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues
View →
Q1
POWERS PYLES SUTTER & VERVILLE, P.C. for YOUTH VILLAGES
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Health Issues
View →
Q1
DLA PIPER LLP (US) for LAZARUS AI
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Intelligence, Health Issues, Defense
View →
Q1
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Defense, Pharmacy
View →
1T
DLA PIPER LLP (US) for INDEPENDENCE BLUE CROSS, LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Health Issues
View →
Q1
POWERS PYLES SUTTER & VERVILLE, P.C. for RWC-340B
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $70,000.00 income
Health Issues
View →
Q1
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Budget/Appropriations
View →
Q1
DLA PIPER LLP (US) for DUKE UNIVERSITY HEALTH SYSTEM
1st Quarter (Jan 1 - Mar 31) 2025 · North Carolina · House · Senate · $20,000.00 income
Health Issues
View →
Q1
AXADVOCACY GOVERNMENT RELATIONS for PROFESSIONAL HOSPITAL GUAYNABO
1st Quarter (Jan 1 - Mar 31) 2025 · PR · House · Senate · $50,000.00 income
Health Issues
View →
Q1
POWERS PYLES SUTTER & VERVILLE, P.C. for REGULATORY RELIEF COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q1
DLA PIPER LLP (US) for BIOHAVEN PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Connecticut · House · Senate · $60,000.00 income
Health Issues
View →
Q1
THE DUBERSTEIN GROUP INC. for EXACT SCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · Wisconsin · House · Senate · $75,000.00 income
Health Issues
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
SIEMENS MEDICAL SOLUTIONS USA, INC for SIEMENS MEDICAL SOLUTIONS USA, INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q1
DLA PIPER LLP (US) for THE JED FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $20,000.00 income
Education, Health Issues
View →
Q1
THE RABEN GROUP for HUMAN MILK BANKING ASSOCIATION OF NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate
Family issues/Abortion/Adoption, Health Issues
View →
Q1
SPLITOAK STRATEGIES LLC for NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
NATIONAL MULTIPLE SCLEROSIS SOCIETY for NATIONAL MULTIPLE SCLEROSIS SOCIETY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
AXADVOCACY GOVERNMENT RELATIONS for NET LEASE CAPITAL
1st Quarter (Jan 1 - Mar 31) 2025 · New Hampshire · House · Senate · $30,000.00 income
Government Issues, Health Issues
View →
Q1
POWERS PYLES SUTTER & VERVILLE, P.C. for AMERICAN SOCIETY OF TRANSPLANT SURGEONS
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $90,000.00 income
Health Issues
View →
Q1
ALSTON & BIRD LLP for KERECIS
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
1T
THE DUBERSTEIN GROUP INC. for PHRMA INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $25,000.00 income
Health Issues
View →
Q1
DLA PIPER LLP (US) for INTRA-CELLULAR THERAPIES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $50,000.00 income
Health Issues
View →
Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q1
KNG HEALTH CONSULTING, LLC for NATIONAL ASSOCIATION OF LONG TERM HOSPITALS
1st Quarter (Jan 1 - Mar 31) 2025 · Connecticut · House · Senate
Health Issues
View →
Previous Page 493 of 614 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem